In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Data demonstrate potential to differentiate between the two major forms of amyloidosis - ATTR and AL - and non invasive detection of systemic AL amyloidosis in multiple organ systems
Dr. Eunice Wang presents results of early-phase studies of investigational targeted treatments for AML; novel menin-KMT2A inhibitor appears to be safe and well-tolerated, and FLT3 inhibitor plus low-dose chemotherapy shows promising efficacy and safety
- BNZ-1 showed an overall response rate (ORR) of 63.2% based on the Global Response Score (GRS) in a heavily pretreated, relapsed and refractory CTCL patient population
- 15 scientific presentations highlight data on BRIVACT® (brivaracetam) CV, NAYZILAM® (midazolam) nasal spray CIV, VIMPAT® (lacosamide) CV, and others, illustrating UCB's commitment to developing new treatment options for patients in their treatment journey